Keratosis Pilaris Treatment Market

Keratosis Pilaris Treatment Market: Overview

• Keratosis Pilaris is a non-contagious skin disorder that causes the outermost layers of skin to thicken, especially on the upper arms and thighs, buttocks, and on the face
• Keratosis pilaris is a harmless skin condition, which causes small, hard bumps that make skin feel like sandpaper. The bumps are often light-colored which usually appear on upper arms, thighs, and buttocks, sometimes with redness or swelling.
• Keratosis pilaris is caused by a buildup of keratin which gets infected by prolonged infection or harmful things. It often affects people with certain skin conditions such as eczema.
• There is no cure for keratosis pilaris but moisturizing lotions or creams may help the skin look and feel better. A variety of these products is available in over-the-counter and prescription mode.
• The global keratosis pilaris treatment market is projected to expand at a significant pace during the forecast period. Increase in prevalence of eczema, rise in prescription rate of treatment for skin disorders by physicians, and increase in awareness about complications of skin allergy & infection are expected to drive the market.

Key Drivers of Global Keratosis Pilaris Treatment Market

• Rise in keratosis pilaris population, increase in demand for number of drugs for keratosis pilaris treatment by physicians, and rise in environmental changes & pollution level in urban cities are expected to drive the global keratosis pilaris treatment market
• According to the British Association of Dermatologists, keratosis pilaris (KP) is present in half the population. It affects 50% to 70% of adolescents and approximately 40% of adults. This usually starts in childhood and becomes more obvious during adolescence and adulthood.
• Increase in preference of keratosis pilaris treatment at home, rise in usage of prescription mode of treatment of keratosis pilaris, and long-lasting results of therapies are important factors likely to fuel the market during the next few years

North America to Hold Major Share of Global Keratosis Pilaris Treatment Market

• North America is projected to account for prominent share of the market during the forecast period. Increase in awareness about keratosis pilaris, high rate of adoption of solutions owing to increased physician prescriptions, and advancements in laser therapy in the U.S. are expected to drive the market in the region.
• Favorable regulation policies, expansion in number of sale through online pharmacies for keratosis pilaris, and rise in funding provided by private players for R&D are anticipated to propel the segment during the forecast period
• Increase in number of visits of patients with keratosis pilaris and focus of new players to enter into partnership with pharmacies are anticipated to propel the market in the U.S.

Key Players Operating in Global Market

Major players operating in the global keratosis pilaris treatment market are:

• Neostrata Company, INC.
• Beiersdorf
• Summit Medical Group
• Dermascope

Global Keratosis Pilaris Treatment Market: Research Scope 

Global Keratosis Pilaris Treatment Market, by Modality

• Over-the-Counter
• Prescription

Global Keratosis Pilaris Treatment Market, by Treatment Type

• Topical Exfoliates
  • Lotions
  • Cream
  • Others
• Topical Retinoid
• Laser Treatment

Global Keratosis Pilaris Treatment Market, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies